Radiation Oncology Market Developments and Forecast by 2031
Radiation Oncology Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (External Beam Radiation Therapy and Internal Beam Radiation Therapy), Application (Breast Cancer, Prostate Cancer, Lung Cancer, Head & Neck Cancer, Cervical Cancer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
- Status : Published
- Report Code : TIPRE00004195
- Category : Life Sciences
- No. of Pages : 170
- Available Report Formats :
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
North America dominated the market in 2023.
The increasing prevalence of cancer and initiatives to support developments in radiation oncology are the pivotal factors fueling the market growth.
The estimated value of the market would be US$ 23,620.56 million by 2031.
Technological advancements are likely to bring attractive trends in the market in the coming years.
Varian Medical Systems Inc, Elekta AB, Accuracy Incorporated, IBA Worldwide (Ion Beam Applications SA), Becton Dickinson & Co, Perspective Therapeutics Inc, Nordion, Mevion Medical Systems, NTP Radioisotopes, and Mallinckrodt Plc are among the key players in the market.
The market is expected to register a CAGR of 13% during 2023–2031.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Radiation Oncology Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Radiation Oncology Market – Key Market Dynamics
5.1 Radiation Oncology Market – Key Market Dynamics
5.2 Market Drivers:
5.2.1 Increasing Prevalence of Cancer
5.2.2 Initiatives to Support Developments in Radiation Oncology
5.3 Market Restraints
5.3.1 High Cost of Radiotherapy Equipment
5.4 Market Opportunities
5.4.1 Strategic Initiatives in Radiation Oncology
5.5 Future Trends
5.5.1 Technological Advancement in Radiation Oncology
5.6 Impact of Drivers and Restraints:
6. Radiation Oncology Market – Global Market Analysis
6.1 Radiation Oncology Market Revenue (US$ Million), 2021–2031
7. Radiation Oncology Market Analysis – by Types
7.1 External Beam Radiation Therapy
7.1.1 Overview
7.1.2 External Beam Radiation Therapy: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Internal Beam Radiation Therapy
7.2.1 Overview
7.2.2 Internal Beam Radiation Therapy: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
8. Radiation Oncology Market Analysis – by Application
8.1 Breast Cancer
8.1.1 Overview
8.1.2 Breast Cancer: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Prostate Cancer
8.2.1 Overview
8.2.2 Prostate Cancer: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Lung Cancer
8.3.1 Overview
8.3.2 Lung Cancer: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Head and Neck Cancer
8.4.1 Overview
8.4.2 Head and Neck Cancer: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
8.5 Cervical Cancer
8.5.1 Overview
8.5.2 Cervical Cancer: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9. Radiation Oncology Market – Geographical Analysis
9.1 North America
9.1.1 North America Radiation Oncology Market Overview
9.1.2 North America: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.1.2.1 North America: Radiation Oncology Market – Revenue and Forecast Analysis – by Types
9.1.2.2 North America: Radiation Oncology Market – Revenue and Forecast Analysis – by External Beam Radiation Therapy
9.1.2.3 North America: Radiation Oncology Market – Revenue and Forecast Analysis – by Internal Beam Radiation Therapy
9.1.2.4 North America: Radiation Oncology Market – Revenue and Forecast Analysis – by Application
9.1.3 North America: Radiation Oncology Market – Revenue and Forecast Analysis – by Country
9.1.3.1 United States: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.1.3.1.1 United States: Radiation Oncology Market Breakdown, by Types
9.1.3.1.2 United States: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.1.3.1.3 United States: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.1.3.1.4 United States: Radiation Oncology Market Breakdown, by Application
9.1.3.2 Canada: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.1.3.2.1 Canada: Radiation Oncology Market Breakdown, by Types
9.1.3.2.2 Canada: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.1.3.2.3 Canada: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.1.3.2.4 Canada: Radiation Oncology Market Breakdown, by Application
9.1.3.3 Mexico: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.1.3.3.1 Mexico: Radiation Oncology Market Breakdown, by Types
9.1.3.3.2 Mexico: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.1.3.3.3 Mexico: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.1.3.3.4 Mexico: Radiation Oncology Market Breakdown, by Application
9.2 Europe
9.2.1 Europe Radiation Oncology Market Overview
9.2.2 Europe: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.2.2.1 Europe: Radiation Oncology Market – Revenue and Forecast Analysis – by Types
9.2.2.2 Europe: Radiation Oncology Market – Revenue and Forecast Analysis – by External Beam Radiation Therapy
9.2.2.3 Europe: Radiation Oncology Market – Revenue and Forecast Analysis – by Internal Beam Radiation Therapy
9.2.2.4 Europe: Radiation Oncology Market – Revenue and Forecast Analysis – by Application
9.2.3 Europe: Radiation Oncology Market – Revenue and Forecast Analysis – by Country
9.2.3.1 Germany: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.2.3.1.1 Germany: Radiation Oncology Market Breakdown, by Types
9.2.3.1.2 Germany: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.2.3.1.3 Germany: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.2.3.1.4 Germany: Radiation Oncology Market Breakdown, by Application
9.2.3.2 United Kingdom: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.2.3.2.1 United Kingdom: Radiation Oncology Market Breakdown, by Types
9.2.3.2.2 United Kingdom: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.2.3.2.3 United Kingdom: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.2.3.2.4 United Kingdom: Radiation Oncology Market Breakdown, by Application
9.2.3.3 France: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.2.3.3.1 France: Radiation Oncology Market Breakdown, by Types
9.2.3.3.2 France: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.2.3.3.3 France: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.2.3.3.4 France: Radiation Oncology Market Breakdown, by Application
9.2.3.4 Spain: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.2.3.4.1 Spain: Radiation Oncology Market Breakdown, by Types
9.2.3.4.2 Spain: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.2.3.4.3 Spain: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.2.3.4.4 Spain: Radiation Oncology Market Breakdown, by Application
9.2.3.5 Italy: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.2.3.5.1 Italy: Radiation Oncology Market Breakdown, by Types
9.2.3.5.2 Italy: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.2.3.5.3 Italy: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.2.3.5.4 Italy: Radiation Oncology Market Breakdown, by Application
9.2.3.6 Rest of Europe: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.2.3.6.1 Rest of Europe: Radiation Oncology Market Breakdown, by Types
9.2.3.6.2 Rest of Europe: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.2.3.6.3 Rest of Europe: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.2.3.6.4 Rest of Europe: Radiation Oncology Market Breakdown, by Application
9.3 Asia Pacific
9.3.1 Asia Pacific Radiation Oncology Market Overview
9.3.2 Asia Pacific: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.3.2.1 Asia Pacific: Radiation Oncology Market – Revenue and Forecast Analysis – by Types
9.3.2.2 Asia Pacific: Radiation Oncology Market – Revenue and Forecast Analysis – by External Beam Radiation Therapy
9.3.2.3 Asia Pacific: Radiation Oncology Market – Revenue and Forecast Analysis – by Internal Beam Radiation Therapy
9.3.2.4 Asia Pacific: Radiation Oncology Market – Revenue and Forecast Analysis – by Application
9.3.3 Asia Pacific: Radiation Oncology Market – Revenue and Forecast Analysis – by Country
9.3.3.1 China: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.3.3.1.1 China: Radiation Oncology Market Breakdown, by Types
9.3.3.1.2 China: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.3.3.1.3 China: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.3.3.1.4 China: Radiation Oncology Market Breakdown, by Application
9.3.3.2 Japan: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.3.3.2.1 Japan: Radiation Oncology Market Breakdown, by Types
9.3.3.2.2 Japan: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.3.3.2.3 Japan: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.3.3.2.4 Japan: Radiation Oncology Market Breakdown, by Application
9.3.3.3 India: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.3.3.3.1 India: Radiation Oncology Market Breakdown, by Types
9.3.3.3.2 India: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.3.3.3.3 India: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.3.3.3.4 India: Radiation Oncology Market Breakdown, by Application
9.3.3.4 Australia: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.3.3.4.1 Australia: Radiation Oncology Market Breakdown, by Types
9.3.3.4.2 Australia: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.3.3.4.3 Australia: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.3.3.4.4 Australia: Radiation Oncology Market Breakdown, by Application
9.3.3.5 South Korea: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.3.3.5.1 South Korea: Radiation Oncology Market Breakdown, by Types
9.3.3.5.2 South Korea: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.3.3.5.3 South Korea: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.3.3.5.4 South Korea: Radiation Oncology Market Breakdown, by Application
9.3.3.5.5 Rest of APAC: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.3.3.5.6 Rest of APAC: Radiation Oncology Market Breakdown, by Types
9.3.3.5.7 Rest of APAC: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.3.3.5.8 Rest of APAC: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.3.3.5.9 Rest of APAC: Radiation Oncology Market Breakdown, by Application
9.4 Middle East and Africa
9.4.1 Middle East and Africa Radiation Oncology Market Overview
9.4.2 Middle East and Africa: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.4.2.1 Middle East and Africa: Radiation Oncology Market – Revenue and Forecast Analysis – by Types
9.4.2.2 Middle East and Africa: Radiation Oncology Market – Revenue and Forecast Analysis – by External Beam Radiation Therapy
9.4.2.3 Middle East and Africa: Radiation Oncology Market – Revenue and Forecast Analysis – by Internal Beam Radiation Therapy
9.4.2.4 Middle East and Africa: Radiation Oncology Market – Revenue and Forecast Analysis – by Application
9.4.3 Middle East and Africa: Radiation Oncology Market – Revenue and Forecast Analysis – by Country
9.4.3.1 Saudi Arabia: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.4.3.1.1 Saudi Arabia: Radiation Oncology Market Breakdown, by Types
9.4.3.1.2 Saudi Arabia: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.4.3.1.3 Saudi Arabia: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.4.3.1.4 Saudi Arabia: Radiation Oncology Market Breakdown, by Application
9.4.3.2 South Africa: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.4.3.2.1 South Africa: Radiation Oncology Market Breakdown, by Types
9.4.3.2.2 South Africa: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.4.3.2.3 South Africa: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.4.3.2.4 South Africa: Radiation Oncology Market Breakdown, by Application
9.4.3.3 United Arab Emirates: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.4.3.3.1 United Arab Emirates: Radiation Oncology Market Breakdown, by Types
9.4.3.3.2 United Arab Emirates: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.4.3.3.3 United Arab Emirates: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.4.3.3.4 United Arab Emirates: Radiation Oncology Market Breakdown, by Application
9.4.3.4 Rest of Middle East and Africa: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.4.3.4.1 Rest of Middle East and Africa: Radiation Oncology Market Breakdown, by Types
9.4.3.4.2 Rest of Middle East and Africa: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.4.3.4.3 Rest of Middle East and Africa: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.4.3.4.4 Rest of Middle East and Africa: Radiation Oncology Market Breakdown, by Application
9.5 South and Central America
9.5.1 South and Central America Radiation Oncology Market Overview
9.5.2 South and Central America: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.5.2.1 South and Central America: Radiation Oncology Market – Revenue and Forecast Analysis – by Types
9.5.2.2 South and Central America: Radiation Oncology Market – Revenue and Forecast Analysis – by External Beam Radiation Therapy
9.5.2.3 South and Central America: Radiation Oncology Market – Revenue and Forecast Analysis – by Internal Beam Radiation Therapy
9.5.2.4 South and Central America: Radiation Oncology Market – Revenue and Forecast Analysis – by Application
9.5.3 South and Central America: Radiation Oncology Market – Revenue and Forecast Analysis – by Country
9.5.3.1 Brazil: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.5.3.1.1 Brazil: Radiation Oncology Market Breakdown, by Types
9.5.3.1.2 Brazil: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.5.3.1.3 Brazil: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.5.3.1.4 Brazil: Radiation Oncology Market Breakdown, by Application
9.5.3.2 Argentina: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.5.3.2.1 Argentina: Radiation Oncology Market Breakdown, by Types
9.5.3.2.2 Argentina: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.5.3.2.3 Argentina: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.5.3.2.4 Argentina: Radiation Oncology Market Breakdown, by Application
9.5.3.3 Rest of South and Central America: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.5.3.3.1 Rest of South and Central America: Radiation Oncology Market Breakdown, by Types
9.5.3.3.2 Rest of South and Central America: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.5.3.3.3 Rest of South and Central America: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.5.3.3.4 Rest of South and Central America: Radiation Oncology Market Breakdown, by Application
10. Radiation Oncology Market – Industry Landscape
10.1 Overview
10.2 Growth Strategies in Radiation Oncology Market
10.3 Organic Growth Strategies
10.3.1 Overview
10.4 Inorganic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Varian Medical Systems Inc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview (Siemens Healthineers AG)
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Elekta AB
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Accuray Incorporated
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 IBA Worldwide (Ion Beam Applications SA)
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Becton Dickinson and Co
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Perspective Therapeutics Inc
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Nordion
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Mevion Medical Systems
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 NTP RADIOISOTOPES
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Mallinckrodt Plc
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
11.11 Provision Healthcare
11.11.1 Key Facts
11.11.2 Business Description
11.11.3 Products and Services
11.11.4 Financial Overview
11.11.5 SWOT Analysis
11.11.6 Key Developments
11.12 Panacea Medical Technologies Pvt. Ltd
11.12.1 Key Facts
11.12.2 Business Description
11.12.3 Products and Services
11.12.4 Financial Overview
11.12.5 SWOT Analysis
11.12.6 Key Developments
11.13 Curium
11.13.1 Key Facts
11.13.2 Business Description
11.13.3 Products and Services
11.13.4 Financial Overview
11.13.5 SWOT Analysis
11.13.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
List of Tables
Table 1. Radiation Oncology Market Segmentation
Table 2. North America: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 3. North America: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 4. North America: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 5. North America: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 6. United States: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 7. United States: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 8. United States: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 9. United States: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 10. Canada: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 11. Canada: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 12. Canada: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 13. Canada: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 14. Mexico: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 15. Mexico: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 16. Mexico: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 17. Mexico: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 18. Europe: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 19. Europe: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 20. Europe: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 21. Europe: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 22. Germany: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 23. Germany: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 24. Germany: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 25. Germany: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 26. United Kingdom: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 27. United Kingdom: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 28. United Kingdom: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 29. United Kingdom: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 30. France: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 31. France: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 32. France: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 33. France: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 34. Spain: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 35. Spain: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 36. Spain: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 37. Spain: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 38. Italy: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 39. Italy: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 40. Italy: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 41. Italy: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 42. Rest of Europe: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 43. Rest of Europe: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 44. Rest of Europe: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 45. Rest of Europe: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 46. Asia Pacific: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 47. Asia Pacific: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 48. Asia Pacific: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 49. Asia Pacific: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 50. China: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 51. China: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 52. China: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 53. China: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 54. Japan: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 55. Japan: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 56. Japan: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 57. Japan: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 58. India: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 59. India: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 60. India: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 61. India: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 62. Australia: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 63. Australia: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 64. Australia: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 65. Australia: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 66. South Korea: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 67. South Korea: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 68. South Korea: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 69. South Korea: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 70. Rest of APAC: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 71. Rest of APAC: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 72. Rest of APAC: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 73. Rest of APAC: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 74. Middle East and Africa: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 75. Middle East and Africa: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 76. Middle East and Africa: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 77. Middle East and Africa: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 78. Saudi Arabia: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 79. Saudi Arabia: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 80. Saudi Arabia: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 81. Saudi Arabia: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 82. South Africa: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 83. South Africa: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 84. South Africa: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 85. South Africa: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 86. United Arab Emirates: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 87. United Arab Emirates: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 88. United Arab Emirates: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 89. United Arab Emirates: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 90. Rest of Middle East and Africa: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 91. Rest of Middle East and Africa: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 92. Rest of Middle East and Africa: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 93. Rest of Middle East and Africa: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 94. South and Central America: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 95. South and Central America: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 96. South and Central America: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 97. South and Central America: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 98. Brazil: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 99. Brazil: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 100. Brazil: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 101. Brazil: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 102. Argentina: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 103. Argentina: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 104. Argentina: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 105. Argentina: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 106. Rest of South and Central America: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 107. Rest of South and Central America: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 108. Rest of South and Central America: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 109. Rest of South and Central America: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 110. Recent Organic Growth Strategies in Radiation Oncology Market
Table 111. Recent Inorganic Growth Strategies in the Radiation Oncology Market
Table 112. Glossary of Terms, Radiation Oncology Market
List of Figures
Figure 1. Radiation Oncology Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Statistics at Glance, Global, 2022
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Radiation Oncology Market Revenue (US$ Million), 2021–2031
Figure 6. Radiation Oncology Market Share (%) – by Types (2023 and 2031)
Figure 7. External Beam Radiation Therapy: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Internal Beam Radiation Therapy: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Radiation Oncology Market Share (%) – by Application (2023 and 2031)
Figure 10. Breast Cancer: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Prostate Cancer: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Lung Cancer: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Head and Neck Cancer: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Cervical Cancer: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. Others: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. North America: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 17. North America: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 18. United States: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 19. Canada: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 20. Mexico: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 21. Europe: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 22. Europe: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 23. Germany: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 24. United Kingdom: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 25. France: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 26. Spain: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 27. Italy: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 28. Rest of Europe: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 29. Asia Pacific: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 30. Asia Pacific: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 31. China: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 32. Japan: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 33. India: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 34. Australia: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 35. South Korea: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 36. Rest of APAC: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 37. Middle East and Africa: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 38. Middle East and Africa: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 39. Saudi Arabia: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 40. South Africa: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 41. United Arab Emirates: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 42. Rest of Middle East and Africa: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 43. South and Central America: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 44. South and Central America: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 45. Brazil: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 46. Argentina: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 47. Rest of South and Central America: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 48. Growth Strategies in Radiation Oncology Market
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For